Concepedia

Author

Peter Alping

Karolinska InstitutetORCID

Also Known As

Doac, Peter Alping

21

Publications

1.3K

Citations

8

H-Index

15

Concepts

All Affiliations

Karolinska InstitutetUniversity of GothenburgKaiser PermanenteKarolinska University HospitalUmeå University
PA

About

Peter Alping is an author at Karolinska Institutet specializing in health policy, epidemiology, and multiple sclerosis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

60

2

Public Health

1

1

60

3

Epidemiology

1

1

60

4

Health Informatics

1

1

60

5

Health Policy

1

1

60

Peter Alping

×

8

Publications

1.3K

Citations

8

H-Index

YearCitations

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

Gustavo Luna, Peter Alping, Joachim Burman,

JAMA Neurology

2019

492

Rituximab in multiple sclerosis

Jonatan Salzer, Rasmus Svenningsson, Peter Alping,

Neurology

2016

340

Rituximab versus fingolimod after natalizumab in multiple sclerosis patients

Peter Alping, Thomas Frisell, Lenka Novakova,

Annals of Neurology

2016

224

Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients

Peter Alping, Johan Askling, Joachim Burman,

Annals of Neurology

2020

130

Validation of the Swedish Multiple Sclerosis Register

Peter Alping, Fredrik Piehl, Annette Langer‐Gould,

Epidemiology

2018

60

Safety of Alemtuzumab and Autologous Hematopoietic Stem Cell Transplantation Compared to Noninduction Therapies for Multiple Sclerosis

Peter Alping, Joachim Burman, Jan Lycke,

Neurology

2021

21

<scp>COMBAT</scp>‐<scp>MS</scp>: A Population‐Based Observational Cohort Study Addressing the Benefit–Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab

Fredrik Piehl, Peter Alping, Suvi Virtanen,

Annals of Neurology

2024

12

Multiple sclerosis, disease-modifying drugs and risk for adverse perinatal and pregnancy outcomes: Results from a population-based cohort study

Katharina Fink, Agnès Gorczyca, Peter Alping,

Multiple Sclerosis Journal

2023

11

Page 1